Both in Surgical Instruments
Boston Scientific vs Medline
Over the past year BSX returned −55.6% and MDLN returned −21.7%; their daily moves had a correlation of 0.20.
BSX −55.6% MDLN −21.7%Growth of $1, one year, split-adjusted
| Metric | BSX | MDLN |
|---|---|---|
| Price | $41.98 | $32.12 |
| Market cap | $60.84B | $28.18B |
| Today | −1.66% | +0.38% |
| 1 month | −2.9% | −8.1% |
| 6 months | −25.7% | −28.2% |
| Year to date | −56.0% | −23.5% |
| 1 year | −58.1% | — |
| Revenue growth (YoY) | +7.5% | — |
| Gross margin | 70.7% | 28.8% |
| Net margin | 16.7% | 0.8% |
| P/E (TTM) | 16.6× | — |
| Price / sales | 2.9× | — |
| Net cash | -$12.09B | -$9.90B |
| Dividend yield | — | — |
| Volatility (60d) | 34.7% | 35.7% |
| Short % of float | 2.8% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).